Compare Biocon Ltd with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs FDC LTD. - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON FDC LTD. BIOCON /
FDC LTD.
 
P/E (TTM) x 22.6 18.0 125.8% View Chart
P/BV x 3.0 2.7 110.6% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 BIOCON    FDC LTD.
EQUITY SHARE DATA
    BIOCON
Mar-18
FDC LTD.
Mar-18
BIOCON /
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs1,188319 372.4%   
Low Rs305164 186.0%   
Sales per share (Unadj.) Rs68.761.6 111.5%  
Earnings per share (Unadj.) Rs7.69.9 75.9%  
Cash flow per share (Unadj.) Rs14.012.0 116.8%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.10-  
Book value per share (Unadj.) Rs86.373.2 118.0%  
Shares outstanding (eoy) m600.00174.40 344.0%   
Bonus/Rights/Conversions ISBB-  
Price / Sales ratio x10.93.9 277.3%   
Avg P/E ratio x98.924.3 407.2%  
P/CF ratio (eoy) x53.420.2 264.7%  
Price / Book Value ratio x8.63.3 261.9%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m447,90042,118 1,063.5%   
No. of employees `0006.15.5 111.2%   
Total wages/salary Rs m9,3112,167 429.7%   
Avg. sales/employee Rs Th6,705.81,943.7 345.0%   
Avg. wages/employee Rs Th1,514.2391.7 386.5%   
Avg. net profit/employee Rs Th736.9313.7 234.9%   
INCOME DATA
Net Sales Rs m41,23410,751 383.5%  
Other income Rs m2,062510 404.6%   
Total revenues Rs m43,29611,260 384.5%   
Gross profit Rs m8,2912,267 365.7%  
Depreciation Rs m3,851351 1,095.9%   
Interest Rs m61514 4,392.9%   
Profit before tax Rs m5,8872,411 244.2%   
Minority Interest Rs m213-5 -4,437.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569671 233.8%   
Profit after tax Rs m4,5311,735 261.1%  
Gross profit margin %20.121.1 95.4%  
Effective tax rate %26.727.8 95.7%   
Net profit margin %11.016.1 68.1%  
BALANCE SHEET DATA
Current assets Rs m41,4867,213 575.2%   
Current liabilities Rs m21,4132,104 1,017.9%   
Net working cap to sales %48.747.5 102.4%  
Current ratio x1.93.4 56.5%  
Inventory Days Days6454 117.4%  
Debtors Days Days9428 339.7%  
Net fixed assets Rs m50,6616,865 738.0%   
Share capital Rs m3,000175 1,712.3%   
"Free" reserves Rs m48,80812,586 387.8%   
Net worth Rs m51,80812,761 406.0%   
Long term debt Rs m17,8986 298,300.0%   
Total assets Rs m99,89715,041 664.2%  
Interest coverage x10.6173.2 6.1%   
Debt to equity ratio x0.30 73,475.8%  
Sales to assets ratio x0.40.7 57.7%   
Return on assets %5.211.6 44.3%  
Return on equity %8.713.6 64.3%  
Return on capital %9.619.0 50.8%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,0581,889 638.4%   
Fx outflow Rs m7,3480-   
Net fx Rs m4,7101,889 249.4%   
CASH FLOW
From Operations Rs m6,6211,498 441.9%  
From Investments Rs m-6,840201 -3,401.3%  
From Financial Activity Rs m-2,397-1,694 141.5%  
Net Cashflow Rs m-2,61210 -25,359.2%  

Share Holding

Indian Promoters % 40.4 68.9 58.6%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 4.7 178.7%  
FIIs % 10.7 7.5 142.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 19.0 104.7%  
Shareholders   109,995 23,730 463.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   TORRENT PHARMA  ALKEM LABORATORIES  ELDER PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare BIOCON With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

CSB Bank IPO, October Passenger Vehicle Sales, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets witnessed buying interest during closing hours and ended on a positive note.

Related Views on News

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Nov 19, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS